|
1) 森島泰雄, 編. In: GVHD予防・治療マニュアル. 東京: 南江堂; 2005
|
|
|
|
|
2) Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor: Japan Marrow Donor Program. N Engl J Med. 1998; 339: 1177-85
|
|
|
|
|
3) Morishima Y, Sasazuki T, Inoko H, et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood. 2002; 99: 4200-6
|
|
|
|
|
|
4) Petersdorf EW, Gooley T, Malkki M, et al. Impact of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donor. In: Hansen J, editors. Immunology of the Human MHC. Vol. I. Seattle: IHWG Press; 2007; p. 1336-50
|
|
|
|
|
|
5) Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007; 110: 4576-83
|
|
|
|
|
|
6)
|
|
|
|
|
|
7) Morishima Y, Yabe T, Matsuo K, et al. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor. Biol Blood Marrow Transplant. 2007; 13: 315-28
|
|
|
|
|
|
8) Shaw BE, Marsh SGE, Mayer NP, et al. HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood. 2006; 107: 1220-6
|
|
|
|
|
|
9) Kawase T, Morishima Y, Matsuo K, et al. High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood. 2007; 110: 2235-42
|
|
|
|
|
|
10) Morishima Y, Kawase T, Malkki M, et al. Effect of HLA-A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors. Tissue Antigens. 2007; 69(Suppl 1): 25-30
|
|
|
|
|
|
11) Ferara GB, Bacigalupo A, Lamparelli T, et al. Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood. 2001; 98: 3150-5
|
|
|
|
|
|
12) Zino E, Frumento G, Marktel S, et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood 2004; 103: 1417-24
|
|
|
|
|
|
13) Fleischhauer K, Locatelli F, Zecca M, et al. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. Blood. 2006; 107: 2984-92
|
|
|
|
|
|
14) Yabe T, Matsuo K, Hirayasu K, et al. Donor killer immunoglobuline-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globuline preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation. Biol Blood Marrow Transplant. 2007; 14: 75-87
|
|
|
|
|
|
15) Bochud PY, Chien JW, Marr KA, et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med. 2008; 359: 1766-77
|
|
|
|
|